AquaPass

Company Overview

Snapshot

Founded in July 2019 by Yaacov Nitzan, AquaPass is a medical device startup with 11–50 employees. The company has secured funding across two rounds from Arbelon Holdings Ltd. and BRM Group. In January 2022, AquaPass received a funding round from Arbelon Holdings Ltd.

Business overview

AquaPass is an early-stage medical device company focused on revolutionizing the treatment of fluid overload. The company develops a noninvasive, drug-free system that removes fluids directly from the interstitial compartment through the skin by enhancing natural perspiration. Its patented system features a wearable body suit with a microclimate generator designed to optimize environmental conditions for perspiration and immediate evaporation, ensuring patient comfort. The AquaPass system aims to provide efficient and safe treatment in various settings, including hospitals, outpatient clinics, and homes, serving the healthcare and life sciences sectors, particularly patients and providers.

Strategic signal

In October 2022, AquaPass's innovative 'evaporation suit' for fluid overload treatment in heart failure patients garnered significant media attention in Israel. This highlights the potential for the company's patented, non-invasive technology to address a critical medical need, signaling strong market interest and validation for its unique approach within the medical device industry.

Company Intelligence Q&A

What is AquaPass's core technology?

AquaPass develops a patented, noninvasive, drug-free fluid overload treatment system. It removes fluids from the interstitial compartment through the skin by controlling and enhancing natural perspiration, using a wearable body suit with a microclimate generator.

When was AquaPass founded?

AquaPass was founded in July 2019.

Who are the founders of AquaPass?

Yaacov Nitzan is a founder and CTO of AquaPass.

Has AquaPass received any funding?

AquaPass has secured funding across two rounds. In January 2022, the company received a funding round from Arbelon Holdings Ltd. Additionally, in July 2019, AquaPass received funding from BRM Group.

What is the current product stage of AquaPass's technology?

AquaPass's product is currently in the Clinical Trial stage, as of October 2022.